MEMPHIS, Tenn. - It's been almost a year since the U.S. Food and Drug Administration (FDA) first announced a shortage of medications used to treat attention-deficit ...
The Drug Enforcement Administration has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in ...
The pervasive challenge of binge eating disorder (BED) extends beyond mere overindulgence, manifesting as a relentless cycle of compulsive eating that profoundly impacts mental, emotional, and ...
To address the nationwide shortage of medications for attention-deficit/hyperactivity disorder, the Drug Enforcement Administration is allowing an increase in the ...
Hikma is introducing generic Vyvanse (lisdexamfetamine dimesylate) 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70mg capsules. “We are pleased to have launched our generic ...
On the face of it, ADHD medications look complicated – there are a lot of them. Not only patients, but many providers have a hard time making sense of them, especially as there are new ones on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback